Healthcare and Life Sciences CFO Insights

CFO Insights

CFOs are leading the path for transformation.

CFOs are leading the path for transformation


With a shift from volume to value, decreased margins, and portfolio rationalization, healthcare and life sciences CFOs must navigate a sea of change.  Learn how KPMG can assist CFOs improve operational effectiveness, implement strategic plans, drive profitable growth, and instate a governance model.

A Preemptive Strike

Higher quantifiable quality will ultimately influence growth, strategy, and brand.

Read more

Potential Tax Implications of Healthcare Reform

Reform legislation (if enacted) would near-certainly include tax law changes—changes that would affect individuals, the healthcare industry, and the business community at large.

Read more


MACRA: The final rule in brief

Understand the impact of the Medicare Access and CHIP Reauthorization Act.

Read more

What Does the Future Hold for the Tax Provisions of the Affordable Care Act?

Review the path legislation might take and the aspects of current healthcare law that could change.

Read more

Medicare Advantage Insight Study

Medicare Advantage may help health plans transition from volume to value.

Read more

Improving the Value of Divestitures

Reduce costs and improve value through strategic M&A transition management.

Read more

A Window to the Future

Global business services yield sustainable improvements and unlock value.

Read more

Connect with us


Request for proposal